Strategy Asset Managers’s Quest Diagnostics DGX Stock Holding History

Strategy Asset Managers’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-5,484	Closed	-$654K	–	257
2020 Q4	$654K	Sell	5,484 -439	-7%	-$53.5K	0.16%	112
2020 Q3	$678K	Buy	+5,923	New	+$700K	0.18%	109
2018 Q1	–	Sell	-22,579	Closed	-$2.22M	–	109
2017 Q4	$2.22M	Sell	22,579 -249	-1%	-$23.6K	0.43%	76
2017 Q3	$2.14M	Buy	+22,828	New	+$2.42M	0.44%	80

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FMI

Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Strategy Asset Managers's DGX Position: Q1 2021 in Review

Strategy Asset Managers sold out of Quest Diagnostics (DGX) in Q1 2021, closing a stake of 5,484 shares — an estimated $654K sold.

Strategy Asset Managers first reported a position in DGX in Q3 2017 and held it in 4 quarters. The position peaked at $2.22M in Q4 2017. 817 funds tracked by Wall St. Rank hold DGX as of Q1 2021.

Strategy Asset Managers reported no remaining Quest Diagnostics position as of Q1 2021 after selling out during the quarter.
Strategy Asset Managers sold 5,484 Quest Diagnostics shares in Q1 2021, an estimated $654K.
Strategy Asset Managers first reported a position in Quest Diagnostics in Q3 2017 and held it in 4 quarters.
Strategy Asset Managers's Quest Diagnostics position peaked at $2.22M in Q4 2017.
817 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2021.

Based on Strategy Asset Managers's 13F filing for Q1 2021, filed 12 May 2021.